MARKET

IBIO

IBIO

IBIO
AMEX

Real-time Quotes | Nasdaq Last Sale

2.600
-0.060
-2.26%
After Hours: 2.610 +0.01 +0.38% 19:59 08/14 EDT
OPEN
2.700
PREV CLOSE
2.660
HIGH
2.727
LOW
2.530
VOLUME
12.30M
TURNOVER
--
52 WEEK HIGH
7.45
52 WEEK LOW
0.0500
MARKET CAP
364.32M
P/E (TTM)
-2.1978
1D
5D
1M
3M
1Y
5Y

EPS

IBIO News

More
Xerox and Inozyme See Activist Action
Icahn Capital lifted its position in printing and imaging firm Xerox to 25,269,522 shares. Longitude Capital initiated a position of 2,819,379 shares in Inozyme, a newly public biopharmaceutical firm.
Barrons.com · 16h ago
Xerox and Inozyme See Activist Action
Barrons.com · 16h ago
Investors bag profits in COVID-19 vaccine players after run-up
Seeking Alpha - Article · 2d ago
Moderna supply deal lifts COVID-19 vaccine players
Seeking Alpha - Article · 3d ago
Russia nod on COVID-19 vaccine a propaganda win for Putin - NYT
Seeking Alpha - Article · 3d ago
Putin claims Russia has developed the first coronavirus vaccine
Seeking Alpha - Article · 4d ago
IBio shares are trading higher after the company provided an update on its Covid-19 vaccine program. Within the update, the company noted anti-SARS-CoV-2 spike titers to IBIO-201 were observed 21 days after immunization.
Benzinga · 4d ago
iBio Provides Update on IBIO-201 COVID-19 Vaccine Program
GlobeNewswire · 5d ago

Industry

Pharmaceuticals
-0.37%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Symbol
Price
%Change

About IBIO

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
More

Webull offers kinds of Ibio Inc stock information, including AMEX:IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.